Annovis Bio, Inc. (ANVS)
0.9934
-0.06
(-5.39%)
USD |
NYSE |
Oct 16, 16:00
1.00
+0.01
(+0.66%)
Pre-Market: 20:00
Annovis Bio Market Cap : 42.32M for Oct. 16, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 16, 2026 | 42.32M |
| October 15, 2026 | 44.74M |
| October 14, 2026 | 43.46M |
| October 13, 2026 | 45.16M |
| October 12, 2026 | 49.00M |
| October 09, 2026 | 51.55M |
| October 08, 2026 | 49.85M |
| October 07, 2026 | 51.55M |
| October 06, 2026 | 50.28M |
| October 05, 2026 | 51.13M |
| October 02, 2026 | 50.28M |
| October 01, 2026 | 49.85M |
| September 30, 2026 | 54.11M |
| September 29, 2026 | 55.39M |
| September 28, 2026 | 58.80M |
| September 25, 2026 | 55.81M |
| September 24, 2026 | 56.67M |
| September 23, 2026 | 54.11M |
| September 22, 2026 | 53.68M |
| September 21, 2026 | 50.70M |
| September 18, 2026 | 48.57M |
| September 17, 2026 | 46.87M |
| September 16, 2026 | 44.31M |
| September 15, 2026 | 47.72M |
| September 14, 2026 | 48.57M |
| Date | Value |
|---|---|
| September 11, 2026 | 47.72M |
| September 10, 2026 | 50.70M |
| September 09, 2026 | 51.98M |
| September 08, 2026 | 55.39M |
| September 04, 2026 | 59.22M |
| September 03, 2026 | 58.80M |
| September 02, 2026 | 72.43M |
| September 01, 2026 | 72.00M |
| August 31, 2026 | 73.28M |
| August 28, 2026 | 73.28M |
| August 27, 2026 | 77.12M |
| August 26, 2026 | 75.84M |
| August 25, 2026 | 77.54M |
| August 24, 2026 | 74.56M |
| August 21, 2026 | 77.54M |
| August 20, 2026 | 76.27M |
| August 19, 2026 | 78.82M |
| August 18, 2026 | 76.69M |
| August 17, 2026 | 74.13M |
| August 14, 2026 | 78.82M |
| August 13, 2026 | 76.27M |
| August 12, 2026 | 76.69M |
| August 11, 2026 | 80.53M |
| August 10, 2026 | 53.94M |
| August 07, 2026 | 53.65M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.291B |
| Alnylam Pharmaceuticals, Inc. | 31.00B |
| Anika Therapeutics, Inc. | 267.39M |
| Savara, Inc. | 914.03M |
| Vericel Corp. | 2.053B |
Market Cap Related Metrics
| Price | 0.9934 |
| Earnings Yield | -180.4% |